Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.670
0.00 (0.00%)
At close: Apr 17, 2026, 4:00 PM EDT
1.750
+0.080 (4.79%)
After-hours: Apr 17, 2026, 4:55 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $12.02 million as of April 17, 2026. Its market cap has decreased by -43.57% in one year.
Market Cap
12.02M
Enterprise Value
1.66M
1-Year Change
-43.57%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $12.02M, a decrease of -98.09%. That is a compound annual growth rate of -54.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 12.02M | 18.40% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 12.38M |
| Imunon | 12.16M |
| NewcelX | 12.13M |
| GT Biopharma | 11.96M |
| CytoMed Therapeutics | 11.95M |
| Theriva Biologics | 11.80M |
| BioVie | 11.76M |
| Genprex | 11.76M |